Viewing Study NCT04164459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2025-12-25 @ 1:27 PM
Study NCT ID: NCT04164459
Status: UNKNOWN
Last Update Posted: 2019-11-15
First Post: 2019-10-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
Sponsor: Taejoon Pharmaceutical Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-12-19
Start Date Type: ACTUAL
Primary Completion Date: 2019-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2020-02
Completion Date Type: ESTIMATED
First Submit Date: 2019-10-15
First Submit QC Date: None
Study First Post Date: 2019-11-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-11-14
Last Update Post Date: 2019-11-15
Last Update Post Date Type: ACTUAL